NCT06094491View on ClinicalTrials.gov

Virtual Diabetes Group Visits Across Health Systems

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
T2DM (Type 2 Diabetes Mellitus)HypertensionHeart Disease ChronicStrokeHyperlipidemiasPeripheral Vascular DiseasesObesity
Interventions
BEHAVIORAL

Virtual Group Visit

Group visits must have these core components: diabetes education, group social support and goal setting.

Trial Locations (2)

60462

Advocate Health Care, Orland Park

60661

Access Community Health Network, Chicago

All Listed Sponsors
collaborator

Wake Forest University Health Sciences

OTHER

collaborator

ACCESS Community Health Network

OTHER

collaborator

Midwest Clinicians' Network

UNKNOWN

collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

University of Chicago

OTHER